中国生化药物杂志
中國生化藥物雜誌
중국생화약물잡지
CHINESE JOURNAL OF BIOCHEMICAL PHARMACEUTICS
2014年
1期
93-94
,共2页
徐健%吴庆琛%陈丹%张诚%张敏%李林俊%熊伟
徐健%吳慶琛%陳丹%張誠%張敏%李林俊%熊偉
서건%오경침%진단%장성%장민%리림준%웅위
开胸术%异丙托溴铵%沐舒坦雾化吸入%肺部并发症
開胸術%異丙託溴銨%沐舒坦霧化吸入%肺部併髮癥
개흉술%이병탁추안%목서탄무화흡입%폐부병발증
thoracotomy%ipratropium bromide%ambroxol aerosol inhalation%pulmonary complications
目的:探讨异丙托溴铵联合沐舒坦雾化吸入对开胸术后肺部并发症的预防效果研究。方法将115例拟行开胸手术患者随机分为2组,2组术前均予常规护理,对照组在此基础上予以沐舒坦雾化吸入,观察组在常规护理基础上联合异丙托溴铵和沐舒坦雾化吸入。结果观察组疗效显著优于对照组(P﹤0.05);观察组肺部感染率显著低于对照组(P﹤0.05)。结论异丙托溴铵联合沐舒坦雾化吸入对开胸术后预防肺部并发症效果显著,并有助于患者恢复。
目的:探討異丙託溴銨聯閤沐舒坦霧化吸入對開胸術後肺部併髮癥的預防效果研究。方法將115例擬行開胸手術患者隨機分為2組,2組術前均予常規護理,對照組在此基礎上予以沐舒坦霧化吸入,觀察組在常規護理基礎上聯閤異丙託溴銨和沐舒坦霧化吸入。結果觀察組療效顯著優于對照組(P﹤0.05);觀察組肺部感染率顯著低于對照組(P﹤0.05)。結論異丙託溴銨聯閤沐舒坦霧化吸入對開胸術後預防肺部併髮癥效果顯著,併有助于患者恢複。
목적:탐토이병탁추안연합목서탄무화흡입대개흉술후폐부병발증적예방효과연구。방법장115례의행개흉수술환자수궤분위2조,2조술전균여상규호리,대조조재차기출상여이목서탄무화흡입,관찰조재상규호리기출상연합이병탁추안화목서탄무화흡입。결과관찰조료효현저우우대조조(P﹤0.05);관찰조폐부감염솔현저저우대조조(P﹤0.05)。결론이병탁추안연합목서탄무화흡입대개흉술후예방폐부병발증효과현저,병유조우환자회복。
Objective To investigate the ipratropium bromide combined with Ambroxol Aerosol Inhalation on preventive effect of pulmonary complications after thoracotomy. Method 115 patients undergoing thoracic operation were randomly divided into 2 groups, 2 groups were given routine nursing before operation, the control group on the basis of Mucosolvan atomization inhalation, the observation group in the conventional nursing combined with ipratropium bromide and atomization inhalation of ambroxol. Results the curative effect of therapeutic group was signiifcantly better than the control group (P<0.05); lung infection in the observation group was significantly lower than that of the control group (P<0.05). Conclusion ipratropium bromide and Mucosolvan aerosol inhalation signiifcantly on the prevention of pulmonary complications after thoracotomy and effect, will help the patient restore.